MURA (Mural Oncology) Accumulated Depreciation : $-37.03 Mil (As of Dec. 2024)

View and export this data going back to 2023. Start your Free Trial

What is Mural Oncology Accumulated Depreciation?

Note: A negative number here means the assets are depreciated. When depricates more, the absolute value gets bigger.

Mural Oncology's quarterly accumulated depreciation increased from Jun. 2024 ($-35.43 Mil) to Sep. 2024 ($-36.33 Mil) and increased from Sep. 2024 ($-36.33 Mil) to Dec. 2024 ($-37.03 Mil).

Mural Oncology's annual accumulated depreciation increased from Dec. 2022 ($-31.35 Mil) to Dec. 2023 ($-33.68 Mil) and increased from Dec. 2023 ($-33.68 Mil) to Dec. 2024 ($-37.03 Mil).

Mural Oncology Accumulated Depreciation Historical Data

The historical data trend for Mural Oncology's Accumulated Depreciation can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Mural Oncology Accumulated Depreciation Chart

Mural Oncology Annual Data

Trend

Dec21

Dec22

Dec23

Dec24

Accumulated Depreciation

-29.81

-31.35

-33.68

-37.03

Mural Oncology Quarterly Data
	Dec21	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Accumulated Depreciation	Get a 7-Day Free Trial						-33.68	-34.53	-35.43	-36.33	-37.03

Mural Oncology Accumulated Depreciation Calculation

The cumulative depreciation of an asset up to a single point in its life. Regardless of the method used to calculate it, the depreciation of an asset during a single period is added to the previous period's accumulated depreciation to get the current accumulated depreciation.

Mural Oncology Accumulated Depreciation Related Terms

Thank you for viewing the detailed overview of Mural Oncology's Accumulated Depreciation provided by GuruFocus.com. Please click on the following links to see related term pages.

Mural Oncology Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Mural Oncology PLC (NAS:MURA) » Definitions » Accumulated Depreciation

Comparable Companies

Traded in Other Exchanges

N/A

Address

10 Earlsfort Terrace, Dublin 2, Dublin, IRL, D02 T380

Website

https://www.muraloncology.com

Mural Oncology PLC is a clinical-stage oncology company whose entire business is focused on discovering and developing immunotherapies that may meaningfully improve the lives of patients with cancer. By leveraging its core competencies in immune cell modulation and protein engineering, It has developed a portfolio of novel, investigational cytokine therapies designed to address areas of unmet need for patients with a variety of cancers. Its product candidate, Nemvaleukin is an investigational, engineered interleukin-2 cytokine designed to capture and expand the therapeutic benefits of high-dose recombinant human IL-2 while mitigating its hallmark toxicities.